Effect of food on the pharmacokinetics of the wee1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors
Authors
Nagard, MSo, K
Ah-See, M
Vermunt, M
Thistlethwaite, Fiona C
Labots, M
Roxburgh, P
Ravaud, A
Campone, M
Valkenburg-van, L
Ottesen, L
Mugundu, G
Affiliation
Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Gaithersburg, USAIssue Date
2018